关注
Filippos Filippatos
Filippos Filippatos
First Department of Pediatrics, Infectious Diseases and Chemotherapy Research Laboratory, Medical School, National and Kapodistrian University of Athens, 'Aghia Sophia' Children's Hospital, 11527Athens, Greece.
在 med.uoa.gr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children
D Lee, J Le Pen, A Yatim, B Dong, Y Aquino, M Ogishi, R Pescarmona, ...
Science 379 (6632), eabo3627, 2022
832022
SARS-CoV-2 variants and effectiveness of vaccines: a review of current evidence
EB Tatsi, F Filippatos, A Michos
Epidemiology & Infection 149, e237, 2021
612021
Association of total and neutralizing SARS-CoV-2 spike-receptor binding domain antibodies with epidemiological and clinical characteristics after immunization with the 1st and …
A Michos, EB Tatsi, F Filippatos, C Dellis, D Koukou, V Efthymiou, ...
Vaccine 39 (40), 5963-5967, 2021
382021
Immune response to SARS-CoV-2 in children: A review of the current knowledge
F Filippatos, EB Tatsi, A Michos
Pediatric Investigation 5 (03), 217-228, 2021
322021
Immunology of multisystem inflammatory syndrome after COVID-19 in children: a review of the current evidence
F Filippatos, EB Tatsi, A Michos
International Journal of Molecular Sciences 24 (6), 5711, 2023
112023
Decreasing incidence of the multisystem inflammatory syndrome in children over 3 pandemic waves
I Eleftheriou, D Maritsi, S Lampidi, K Charisi, P Vantsi, K Skourti, ...
The Pediatric Infectious Disease Journal 42 (2), 122-124, 2023
102023
Post‑COVID‑19 syndrome in children
F Filippatos, EB Tatsi, A Michos
Experimental and Therapeutic Medicine 24 (4), 1-10, 2022
102022
Seroepidemiology of SARS‐CoV‐2 in pediatric population during a 16‐month period prior to vaccination
F Filippatos, EB Tatsi, C Dellis, V Efthymiou, A Margeli, I Papassotiriou, ...
Journal of Medical Virology 94 (5), 2174-2180, 2022
92022
SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance
F Filippatos, EB Tatsi, C Dellis, DM Koukou, C Papagiannopoulos, ...
Epidemiology & Infection 150, e177, 2022
92022
Time of day of BNT162b2 COVID-19 immunization affects total SARS-CoV-2 antibody levels but not neutralizing activity
F Filippatos, EB Tatsi, V Efthymiou, V Syriopoulou, A Michos
Journal of biological rhythms 37 (5), 562-566, 2022
82022
Association of clinical and epidemiological characteristics with COVID-19 BNT162b2 mRNA vaccine short-term adverse reactions in healthcare workers
F Filippatos, EB Tatsi, C Dellis, N Dessypris, V Syriopoulou, A Michos
Human Vaccines & Immunotherapeutics 17 (12), 4755-4760, 2021
82021
Immunogenicity of the COVID-19 BNT162b2 vaccine in adolescents and young adults with cystic fibrosis
A Michos, F Filippatos, EB Tatsi, C Dellis, V Efthymiou, I Zarkada, E Troupi, ...
Journal of Cystic Fibrosis 21 (3), e184-e187, 2022
72022
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
P Bastard, A Gervais, M Taniguchi, L Saare, K Särekannu, T Le Voyer, ...
Journal of Experimental Medicine 221 (2), e20231353, 2024
42024
Multisystem inflammatory syndrome in children (MIS-C): A nationwide collaborative study in the Greek population
S Lampidi, D Maritsi, M Charakida, I Eleftheriou, E Farmaki, N Spyridis, ...
European Journal of Pediatrics 183 (4), 1693-1702, 2024
32024
Ultra-fast and sensitive screening for antibodies against the SARS-CoV-2 S1 spike antigen with a portable bioelectric biosensor
S Mavrikou, GM Papaioannou, V Tsekouras, K Hatziagapiou, EB Tatsi, ...
Chemosensors 10 (7), 254, 2022
32022
Group A streptococcus infection in neonatal population: a systematic review of the literature
R Sokou, F Filippatos, V Daniil, ED Bikouli, AG Tsantes, D Piovani, ...
Journal of Clinical Medicine 12 (22), 6974, 2023
12023
Molecular characterization of VP6 and NSP4 genes of unusual G and P Rotavirus group A isolated from children with acute gastroenteritis
C Dellis, EB Tatsi, DM Koukou, F Filippatos, E Vetouli, A Michos, ...
12023
Kinetics of SARS-CoV-2 Spike Antibodies after the Second and Third Dose of the BNT162b2 COVID-19 Vaccine and Association with Epidemiological Characteristics and Breakthrough …
EB Tatsi, F Filippatos, C Dellis, MM Dourdouna, V Syriopoulou, A Michos
Microorganisms 11 (8), 2010, 2023
12023
Comparison of a rapid fluorescence immunochromatographic test with an enzyme-linked immunosorbent assay for measurement of SARS-CoV-2 spike protein antibody neutralizing activity
F Filippatos, EB Tatsi, C Papagiannopoulos, V Syriopoulou, A Michos
Journal of Virological Methods 316, 114728, 2023
12023
1093. Multiparametric Investigation Of Spike-Protein Specific T-cell Cytokine Expression Profile In Children With Symptomatic COVID-19 Or Multisystem Inflammatory Syndrome
F Filippatos, M Tzanoudaki, EB Tatsi, V Efthymiou, M Liatsis, ...
Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 933, 2022
12022
系统目前无法执行此操作,请稍后再试。
文章 1–20